Stay updated on Postmenopausal Breast Cancer ARV-471 vs Anastrozole Clinical Trial
Sign up to get notified when there's something new on the Postmenopausal Breast Cancer ARV-471 vs Anastrozole Clinical Trial page.

Latest updates to the Postmenopausal Breast Cancer ARV-471 vs Anastrozole Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study's location listings were updated, adding new sites across several U.S. states and in Spain (Galicia and Santa Cruz de Tenerife). The page also removed some previously listed location blocks, reflecting a revision to the site deployment (transition to revision 3.3.3).SummaryDifference0.8%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedRevision metadata updated: added v3.3.2 and removed v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check50 days agoChange DetectedThe government funding/operating status notice is removed from the page.SummaryDifference0.3%

- Check64 days agoChange DetectedScreenshots show only non-substantive UI/layout updates to the study details page, and the core study information appears unchanged; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check93 days agoChange DetectedMajor addition of a funding/operating status notice and a new version tag (v3.2.0) with guidance on where to check status; the previous v3.1.0 revision is removed.SummaryDifference3%

- Check100 days agoChange DetectedUpgrade version from v3.0.2 to v3.1.0; no other content changes are specified.SummaryDifference0.1%

Stay in the know with updates to Postmenopausal Breast Cancer ARV-471 vs Anastrozole Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Postmenopausal Breast Cancer ARV-471 vs Anastrozole Clinical Trial page.